Company Profile

Immunarray USA Inc
Profile last edited on: 7/19/2023      CAGE: 76T06      UEI: FZN2BT63CEN3

Business Identifier: Novel blood based tests to support diagnosis-management of complex acute and chronic immune-mediated and neurodegenerative diseases
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

737 North 5th Street Suite 304
Richmond, VA 23219
   (804) 212-2974
Location: Single
Congr. District: 04
County: Richmond city

Public Profile

Headquartered in Richmnd, VA but having facilities also in Rehovot, Israel, Imunoarray is anchored in iCHIP® , a technology licensed from the Weizmann Institute of Science, ImmunArray is a molecular diagnostics company developing of novel blood based tests to support the diagnosis and management of complex acute and chronic immune-mediated and neurodegenerative diseases. The company’s tests measure the repertoire of circulating antibodies to an array of antigens which are printed on ImmunArray’s proprietary iCHIP®. This circulating antibody ‘fingerprint’ is compared to the Company’s proprietary database of affected and healthy fingerprints, and proprietary algorithms are used to enable diagnosis of the likelihood of disease or drug response. Repeated testing enable observation of changes in a patient’s autoantibody signatures over time. The company is organzied around enabling physicians to manage complex autoimmune and neurologic diseases, including traumatic brain injury, by providing them with information from proprietary multi-analyte biomarker-based tests coming out of work unertaken in collaboration with clinicians, partners and medical centers in the USA, Europe and Israel. ImmunArray Ltd. also has worldwide exclusive licenses from Johns Hopkins University in the field of brain injury, Brigham and Women’s in Multiple Sclerosis in addition to the firm's own body of filed patents.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Donna J Edmonds -- CEO and Chairman of the Board

  Nathan Hunt

  Pennina Safer -- CSO, CTO, GM Israel

  Timothy E Vanmeter

  Steven J Wallac -- COO

Company News

There are no news available.